Advanced Biomed Inc.
Financial highlights
| Metric | FY June 30, 2025 | FY June 30, 2024 |
|---|---|---|
| Operating expenses | $3.0M | $2.5M |
| Cash from operations | -$5.8M | -$2.1M |
| Capital expenditure | $31,650 | $74,110 |
| Free cash flow | -$5.9M | -$2.2M |
| Total assets | $6.5M | $4.5M |
| Total liabilities | $3.0M | $2.8M |
Shares outstanding 1.4M · Free float 100.0%
Annual filing data through FY ended June 30, 2025; float as of June 27, 2026.